TP53 and cancer: Numerous studies have demonstrated the contributions of p53 GOF phenotypes to malignancy through mechanisms involving proliferation, migration, invasion, metastasis, drug resistance, colony formation, genomic instability and cancer cell survival [11, 12, 27, 28].